Now a study of 60 COVID-19 patients
published in Lancet this week finds that 55% of them were still displaying such neurological symptoms during follow-up visits three months later. And when doctors compared brain scans of these 60 COVID patients with those of a control group who had not been infected, they found that the brains of the COVID patients showed structural changes that correlated with memory loss and smell loss.
And that’s not exclusive to adults. A case study published in
JAMA Neurology in June highlighted four U.K. children with
multisystem inflammatory syndrome, a severe and potentially fatal condition that appears to be linked to COVID-19. These children developed neurological manifestations such as headaches, muscle weakness, confusion and disorientation. While two of the kids recovered, the other two continued to show symptoms, including muscle weakness so severe that they needed a wheelchair.